"大阪「梅田駅」から徒歩３分の皮膚科・美容皮膚科・再生医療「インフュージョンクリニック」。一般内科からリウマチ治療・メンタル・心理カウンセリングまで幅広く診察しております。炎症性腸疾患とリウマチといういわゆる難病を専門的に診療する日本で初めてのインフュージョンクリニックとして2010年に私たちはスタートしました。【再生医療】変形性膝関節症の治療にバイオセラピーを導入しています。バイオセラピーとは、自分や他人の細胞や血液由来の成分を使い、病気の治療や痛んだ組織の修復を行う新しい治療法です。膝が痛くて歩きにくい方、ヒアルロン酸注射を何度も打っている方、痛みが改善しないが、手術は受けたくないという方などが対象になります。【美容皮膚科】近年では、加齢に伴う肌の変化に対しても医学的根拠をもとに治療が行われるようになってきました。個人にあった治療の内容を選択し安全性の高い美容診療も行っております。(自費治療)【心理カウンセリング】身体に問題を抱えている場合はもちろん、身体には特に問題がなくても、人は心に負担を感じてしまうことがあります。自分ではどう対処すればいいのかがわからないこともあります。そんな方のために心理カウンセリングの場をご提供します。あがり症、漠然とした不安、 抑うつ気分、悪夢、摂食障害、難聴、ダイエット、自分ではコントロールできない感覚などを、薬を用いず心理的側面からカウンセリングケアします。症状が改善してきましたら徐々に回数を減らし完治を目指します。 (ご希望によりいつでもケアを完了できます。)当院は、JR大阪駅より直結の場所にあり、アクセスが便利となっております。大阪で再生医療、リウマチの最先端医療なら 医療法人錦秀会インフュージョンクリニックへ。"

During the past decade, Kinshukai Infusion Clinic conducted 22 clinical trials. In the 10-year time frame, 22 clinical trials started and 8 clinical trials were completed, i.e. on average, 36.4% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 8 clinical trials were completed. i.e. 133.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Kinshukai Infusion Clinic" #1 sponsor was "Eli Lilly and Company" with 5 trials, followed by "Janssen Research & Development, LLC" with 5 trials sponsored, "Shire" with 5 trials sponsored, "Galapagos NV" with 3 trials sponsored and "Takeda" with 3 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kinshukai Infusion Clinic" #1 collaborator was "Gilead Sciences" with 3 trials as a collaborator, "Galapagos NV" with 1 trials as a collaborator and "Nektar Therapeutics" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Kinshukai Infusion Clinic" are "Crohn's Disease" (11 trials), "Ulcerative Colitis" (7 trials), "Colitis, Ulcerative" (4 trials), "Crohn Disease" (1 trials) and "Fistulizing Crohns Disease" (1 trials). Many other conditions were trialed in "Kinshukai Infusion Clinic" in a lesser frequency.

Most popular intervention types in "Kinshukai Infusion Clinic" are "Drug" (21 trials), "Other" (4 trials) and "Biological" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (16 trials), "Filgotinib" (4 trials), "Guselkumab" (4 trials), "Ontamalimab" (4 trials) and "Guselkumab Dose 1" (3 trials). Other intervention names were less common.

The vast majority of trials in "Kinshukai Infusion Clinic" are 22 trials for "All" genders.

Currently, there are NaN active trials in "Kinshukai Infusion Clinic". undefined are not yet recruiting, 6 are recruiting, 6 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 5 completed trials in Kinshukai Infusion Clinic, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Kinshukai Infusion Clinic, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 18 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".